Literature DB >> 33611593

Rare Activating BRAF Alteration Involving the β3-αC Kinase Domain in Ganglioglioma.

Chun-Chieh Lin1, Joel A Lefferts1, Amy M Chan2, George Zanazzi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33611593      PMCID： PMC8786492          DOI： 10.1093/jnen/nlab013

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN： 0022-3069            Impact factor:   3.685


× No keyword cloud information.
  10 in total

1.  Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2.

Authors:  Scott A Foster; Daniel M Whalen; Ayşegül Özen; Matthew J Wongchenko; JianPing Yin; Ivana Yen; Gabriele Schaefer; John D Mayfield; Juliann Chmielecki; Philip J Stephens; Lee A Albacker; Yibing Yan; Kyung Song; Georgia Hatzivassiliou; Charles Eigenbrot; Christine Yu; Andrey S Shaw; Gerard Manning; Nicholas J Skelton; Sarah G Hymowitz; Shiva Malek
Journal:  Cancer Cell       Date:  2016-03-17       Impact factor: 31.743

Review 2.  MAPK signal pathways in the regulation of cell proliferation in mammalian cells.

Authors:  Wei Zhang; Hui Tu Liu
Journal:  Cell Res       Date:  2002-03       Impact factor: 25.617

3.  Intracranial ganglioglioma: clinicopathological and MRI findings in 16 patients.

Authors:  D Zhang; T D Henning; L-G Zou; L-B Hu; L Wen; X-Y Feng; S-H Dai; W-X Wang; Q-R Sun; Z-G Zhang
Journal:  Clin Radiol       Date:  2007-11-05       Impact factor: 2.350

4.  Allosteric activation of functionally asymmetric RAF kinase dimers.

Authors:  Jiancheng Hu; Edward C Stites; Haiyang Yu; Elizabeth A Germino; Hiruy S Meharena; Philip J S Stork; Alexandr P Kornev; Susan S Taylor; Andrey S Shaw
Journal:  Cell       Date:  2013-08-29       Impact factor: 41.582

Review 5.  A neuropathology-based approach to epilepsy surgery in brain tumors and proposal for a new terminology use for long-term epilepsy-associated brain tumors.

Authors:  Ingmar Blumcke; Eleonora Aronica; Horst Urbach; Andreas Alexopoulos; Jorge A Gonzalez-Martinez
Journal:  Acta Neuropathol       Date:  2014-05-25       Impact factor: 17.088

6.  The genetic landscape of ganglioglioma.

Authors:  Melike Pekmezci; Javier E Villanueva-Meyer; Benjamin Goode; Jessica Van Ziffle; Courtney Onodera; James P Grenert; Boris C Bastian; Gabriel Chamyan; Ossama M Maher; Ziad Khatib; Bette K Kleinschmidt-DeMasters; David Samuel; Sabine Mueller; Anuradha Banerjee; Jennifer L Clarke; Tabitha Cooney; Joseph Torkildson; Nalin Gupta; Philip Theodosopoulos; Edward F Chang; Mitchel Berger; Andrew W Bollen; Arie Perry; Tarik Tihan; David A Solomon
Journal:  Acta Neuropathol Commun       Date:  2018-06-07       Impact factor: 7.801

7.  Lack of Response to Vemurafenib in Melanoma Carrying BRAF K601E Mutation.

Authors:  Fedor V Moiseyenko; Vitaliy V Egorenkov; Mikhail M Kramchaninov; Elizaveta V Artemieva; Svetlana N Aleksakhina; Maxim M Holmatov; Vladimir M Moiseyenko; Evgeny N Imyanitov
Journal:  Case Rep Oncol       Date:  2019-05-16

8.  Recurrent somatic BRAF insertion (p.V504_R506dup): a tumor marker and a potential therapeutic target in pilocytic astrocytoma.

Authors:  Fida Khater; Sylvie Langlois; Pauline Cassart; Anne-Marie Roy; Mathieu Lajoie; Jasmine Healy; Chantal Richer; Pascal St-Onge; Nelson Piché; Sebastien Perreault; Sonia Cellot; Monia Marzouki; Nada Jabado; Daniel Sinnett
Journal:  Oncogene       Date:  2018-12-21       Impact factor: 9.867

9.  BRAF activating mutations involving the β3-αC loop in V600E-negative anaplastic pleomorphic xanthoastrocytoma.

Authors:  Drew Pratt; Sandra Camelo-Piragua; Kathryn McFadden; Denise Leung; Rajen Mody; Arul Chinnaiyan; Carl Koschmann; Sriram Venneti
Journal:  Acta Neuropathol Commun       Date:  2018-03-15       Impact factor: 7.801

Review 10.  Emerging BRAF Mutations in Cancer Progression and Their Possible Effects on Transcriptional Networks.

Authors:  Magdalena Śmiech; Paweł Leszczyński; Hidetoshi Kono; Christopher Wardell; Hiroaki Taniguchi
Journal:  Genes (Basel)       Date:  2020-11-12       Impact factor: 4.096
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.